Gain-of-function mutations in SAMD9 and SAMD9L, located on chromosome 7, enhance antiproliferative effects, leading to pancytopenia and restricted growth or organ hypoplasia in non-hematopoietic tissues [44]. Here, SAMD9L is linked to Pancytopenia.